Detalhe da pesquisa
1.
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.
BMC Cancer
; 23(1): 112, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721174
2.
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Qual Life Res
; 30(11): 3255-3266, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387291
3.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717303
4.
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 167(3): 659-669, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058175
5.
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 168(1): 127-134, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164421
6.
N-Acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs.
J Physiol
; 595(4): 1077-1092, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739590
7.
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 154(2): 351-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26536871
8.
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(11): 1269-78, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273342
9.
First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysis.
J Oncol Pharm Pract
; 20(5): 362-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24158979
10.
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Lancet Oncol
; 14(8): 697-710, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23746666
11.
Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.
Oncologist
; 18(6): 667-74, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23723333
12.
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
Breast Cancer Res Treat
; 139(2): 411-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23649189
13.
Specific anticancer treatments in the last 3 months of life: a French experience.
Support Care Cancer
; 21(2): 405-12, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736464
14.
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?
Int J Clin Oncol
; 18(4): 607-13, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22763660
15.
[Diagnosis and management of interstitial lung disease induced by antibody-drug conjugates in breast cancer: A French expert opinion paper]. / Diagnostic et prise en charge de la pneumopathie interstitielle diffuse induite par les anticorps conjugués dans le cancer du sein : avis d'expert.
Bull Cancer
; 110(9): 937-949, 2023 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-37331827
16.
Characterizing Organizational Lifecycle through Strategic and Structural Flexibility: Insights from MSMEs in Mexico.
Glob J Flex Syst Manag
; 23(2): 271-290, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522094
17.
Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(5): 698-705, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238873
18.
Beneficial effects of melatonin on prostanoids pathways in pulmonary hypertensive neonates.
Vascul Pharmacol
; 138: 106853, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766627
19.
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.
Anticancer Drugs
; 21(10): 958-62, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20856105
20.
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
JAMA Oncol
; 4(7): 977-984, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566104